2.50
Hdl Handle:
http://hdl.handle.net/10541/84115
Title:
Chemotherapy for advanced non-small cell lung cancer.
Authors:
Thatcher, Nick
Abstract:
Chemotherapy for advanced NSCLC in good performance status has survival benefit, reduces tumour symptoms and can improve quality of life. Future challenges include defining the optimal chemotherapy and incorporating the newer agents to improve patients' outcome. In particular treatment of the elderly and patients with poorer performance status need to be developed with more attention being paid to relief of symptoms and minimising treatment toxicity.
Affiliation:
Christie and Wythenshawe Hospitals, Wilmslow Road, M20 4BX, Manchester, UK. linda.aschcroft@christie-tr.nwest.nhs.uk
Citation:
Chemotherapy for advanced non-small cell lung cancer. 2001, 34 Suppl 2:S171-5 Lung Cancer
Journal:
Lung Cancer
Issue Date:
Dec-2001
URI:
http://hdl.handle.net/10541/84115
PubMed ID:
11720761
Type:
Article
Language:
en
ISSN:
0169-5002
Appears in Collections:
All Christie Publications

Full metadata record

DC FieldValue Language
dc.contributor.authorThatcher, Nicken
dc.date.accessioned2009-10-13T08:23:01Z-
dc.date.available2009-10-13T08:23:01Z-
dc.date.issued2001-12-
dc.identifier.citationChemotherapy for advanced non-small cell lung cancer. 2001, 34 Suppl 2:S171-5 Lung Canceren
dc.identifier.issn0169-5002-
dc.identifier.pmid11720761-
dc.identifier.urihttp://hdl.handle.net/10541/84115-
dc.description.abstractChemotherapy for advanced NSCLC in good performance status has survival benefit, reduces tumour symptoms and can improve quality of life. Future challenges include defining the optimal chemotherapy and incorporating the newer agents to improve patients' outcome. In particular treatment of the elderly and patients with poorer performance status need to be developed with more attention being paid to relief of symptoms and minimising treatment toxicity.en
dc.language.isoenen
dc.subjectLung Canceren
dc.subjectCancer Stagingen
dc.subject.meshAdult-
dc.subject.meshAge Factors-
dc.subject.meshAged-
dc.subject.meshAntineoplastic Combined Chemotherapy Protocols-
dc.subject.meshCarcinoma, Non-Small-Cell Lung-
dc.subject.meshHealth Status-
dc.subject.meshHumans-
dc.subject.meshLung Neoplasms-
dc.subject.meshMiddle Aged-
dc.subject.meshNeoplasm Staging-
dc.subject.meshPrognosis-
dc.subject.meshQuality of Life-
dc.subject.meshRandomized Controlled Trials as Topic-
dc.subject.meshSurvival Analysis-
dc.titleChemotherapy for advanced non-small cell lung cancer.en
dc.typeArticleen
dc.contributor.departmentChristie and Wythenshawe Hospitals, Wilmslow Road, M20 4BX, Manchester, UK. linda.aschcroft@christie-tr.nwest.nhs.uken
dc.identifier.journalLung Canceren

Related articles on PubMed

All Items in Christie are protected by copyright, with all rights reserved, unless otherwise indicated.